TrialNet

Eligibility:

• For Individuals who are 2-45 years of age with a parent, child, brother, or sister with T1D.
• For Individuals who are 2-20 years of age with a niece, nephew, aunt, uncle, grandparent, half-sibling or cousin with T1D.

Or

• Are between the ages of 2 and 45 years and have tested positive for at least one type 1 diabetes related autoantibody outside of TrialNet.
• Have not been diagnosed with diabetes.

Purpose: This study helps to identify family members of people with T1D who might have antibodies associated with T1D. Relatives of people with T1D have a 3-4 percent chance of testing positive for antibodies. If participants are found to be antibody positive they will be offered follow up screening and further tests to determine their risk for T1D. Depending on the outcome of those tests, participants may qualify for prevention studies offered by TrialNet.

For more information visit TrialNet on the web. 

Coordinators:  Juanita O'Brian, CMA, CCRC; Henry Rodriguez, MD

Contact: usfdiabetesresearchc@usf.edu | Phone Number: (813) 974-9817

Longitudinal Study and Registry of Bone Health

Eligibility:

• For women age 65+ and men age 70+
• Diagnosis of osteoporosis or abnormal Bone Mineral Density OR History of fracture

Purpose: To create a comprehensive database of patients with abnormal bone mineral density (BMD)/fragility fractures and/or presence of risk factors, regardless of the etiology for clinical and research use, with the ability to analyze patterns, quality, and costs of care over time along with monitoring screening, treatment and outcomes.

Coordinator: Iryna Pestun, MD

Contact: bonehealthregistry@epi.usf.edu | Phone Number: (813) 974-9295

Study Flyer

The USF Diabetes Center is an international leader in Type 1 diabetes research. Our program’s goals are to help families with type 1 diabetes by investigating ways to prevent onset of the disease, to identify at-risk individuals years before clinical symptoms occur and to test cutting edge new therapies for those living with T1D.

In addition to its role participating in T1D research, the USF Diabetes Center is a global leader in the Type 1 Diabetes TrialNet research consortium as one of twenty TrialNet Clinical Centers worldwide.The USF Diabetes Center also offers a number of research opportunities to individuals living with Type 2 diabetes (T2D) with a focus on developing new therapies for children and adolescents with T2D.